Characterization of Marburg virus glycoprotein in viral entry. (Q40228983)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Characterization of Marburg virus glycoprotein in viral entry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jizhen Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Emily Rumschlag

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Stéphanie Tymen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Valentina Volchkova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lijun Rong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

20 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

18 September 2017

volume

358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

79-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16989883%20AND%20SRC:MED&resulttype=core&format=json

Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Ebola and Marburg virus-like particles activate human myeloid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Ectodomain shedding of the glycoprotein GP of Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Biosynthesis and role of filoviral glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Ebola virus ecology: a continuing mystery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Covalent modifications of the ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Resistance to infection by subgroups B, D, and E avian sarcoma and leukosis viruses is explained by a premature stop codon within a resistance allele of the tvb receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Fruit bats as reservoirs of Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Comprehensive analysis of ebola virus GP1 in viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Receptor interference mediated by the envelope glycoproteins of various HIV-1 and HIV-2 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Retroviral superinfection resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Ecologic and geographic distribution of filovirus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Variation in the Glycoprotein and VP35 Genes of Marburg Virus Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Infection and activation of monocytes by Marburg and Ebola viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Proteolytic processing of Marburg virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Immunization for Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041

inferred from DOI database lookup

7 January 2021

based on heuristic

The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.041